-- 
Israeli Stocks: Teva Pharmaceutical, Gadot Biochemical, Biondvax

-- B y   S h a r o n   W r o b e l
-- 
2011-08-30T14:23:08Z

-- http://www.bloomberg.com/news/2011-08-30/israeli-stocks-teva-israel-land-development-biondvax.html
Israel ’s TA-25 Index dropped for the
first time in three days, declining 0.1 percent to 1,121.17 at
the 4:30 p.m. close in  Tel Aviv . Investors traded about 1.02
billion shekels ($285.5 million) of shares and convertible
securities today, according to Tel Aviv Stock Exchange data.  The following stocks rose or fell today. Symbols are in
parentheses.  Biondvax Pharmaceuticals Ltd. (BNDX)   gained 13 percent,
the most since Oct. 24, to 1.615 shekels. The maker of flu
vaccines received approval to conduct a Phase II clinical trial
of its universal  flu vaccine  at hospitals in  Jerusalem  and Tel
Aviv.  Gadot Biochemical Industries Ltd. (GDBC IT) surged the most
since at least May 2005 when Bloomberg began tracking the
shares, more than doubling to 3.998 shekels. Delek Investments &
Properties Ltd. offered to buy the shares of the maker of food
and cosmetic ingredients from the public.  Teva Pharmaceutical Industries Ltd. (TEVA)   advanced to
the highest since Aug. 4, increasing 0.9 percent to 143.80
shekels. Mylan Inc.’s motion to dismiss a patent lawsuit by the
world’s largest maker of generic drugs over the multiple-
sclerosis drug Copaxone, was dismissed by a U.S. federal judge.  To contact the reporter on this story:
{Sharon Wrobel} in Tel Aviv at 
 swrobel4@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  